TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update May 15, 2024
TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors May 10, 2024
TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting April 24, 2024
TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities April 17, 2024
TScan Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update March 6, 2024
